Skip to main content
. 2020 Nov 16;12(11):3385. doi: 10.3390/cancers12113385

Figure 1.

Figure 1

Adaptive immune response and systemic immune dysfunction in cancer. Upon engulfing tumor antigens dendritic cells (DCs) migrate to lymph nodes. There they initiate anti-tumor immunity, with the activation of CD8+ T cells. DC dysfunction in cancer hosts leads to inefficient T cell response. DCs can induce tolerance with the differentiation of CD4+ T cells into regulatory T cells. Altered systemic immunity affects immune niches in distant organs.